Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components

v3.23.1
Balance Sheet Components
3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components Balance Sheet Components
Accounts Receivable, Net
Accounts receivable, net consisted of the following:
March 31, December 31,
2023 2022
(In thousands)
Trade receivables $ 14,414  $ 9,639 
Less: Allowances for credit losses (67) (454)
Total $ 14,347  $ 9,185 
Inventories
Inventories consisted of the following:
March 31, December 31,
2023 2022
(In thousands)
Raw materials $ 62,662  $ 58,585 
Work-in-progress 8,534  12,617 
Finished goods 2,741  — 
Total $ 73,937  $ 71,202 
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following:
March 31, December 31,
2023 2022
(In thousands)
Prepaid insurance and other $ 2,757  $ 3,316 
Vendor prepayments 1,818  2,217 
Total $ 4,575  $ 5,533 
Property and Equipment, Net
Property and equipment, net consisted of the following:
March 31, December 31,
2023 2022
(In thousands)
Computers and software $ 2,272  $ 2,222 
Lab equipment and other equipment 7,630  7,379 
Furniture and fixtures 240  181 
Leasehold improvements 15,948  16,273 
Construction in progress 21  — 
Total property, plant and equipment 26,111  26,055 
Less accumulated depreciation and amortization (7,036) (6,243)
Property, plant and equipment, net $ 19,075  $ 19,812 
Depreciation expense for the three months ended March 31, 2023 and 2022 was $1.2 million and $0.5 million, respectively.
The manufacturing facility operating lease at Campbell (McGlincy) was terminated on March 31, 2023, and is no longer in use. There were no significant asset retirement obligations. The Company wrote-off $0.6 million in fully-depreciated leasehold improvements during the three months ended March 31, 2023.
Other Assets
Other assets consisted of the following:
March 31, December 31,
2023 2022
(In thousands)
Right of use assets 12,855  13,545 
Net investments in sales-type lease 6,288  6,554 
Non-current prepaid expenses and other assets 3,912  3,211 
Total Other assets $ 23,055  $ 23,310 

Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following:
March 31, December 31,
2023 2022
(In thousands)
Accrued expenses $ 8,586  $ 8,602 
Accrued salaries and benefits 2,812  4,830 
Lease liability – current portion 2,407  2,445 
Total Accrued expenses and other current liabilities $ 13,805  $ 15,877 
Other Noncurrent Liabilities
Other noncurrent liabilities consisted of the following:
March 31, December 31,
2023 2022
(In thousands)
Lease liabilities - noncurrent portion $ 11,606  $ 12,206 
Other noncurrent liabilities 330  428 
Total other noncurrent liabilities $ 11,936  $ 12,634 
Please refer to Note 10, Equity Instruments, for further details of the contingent earnout liability and warrant liabilities.